Jun 6, 2023 8:00 am EDT iBio Expands Tech Stack with EngageTx™; Adds TROP-2 Bispecific to Development Pipeline
Apr 4, 2023 4:05 pm EDT iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
Jan 5, 2023 8:00 am EST iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine